Literature DB >> 26181835

A pediatric case of hepatitis B virus subgenotype A2 in Japan.

Kazuhiko Hayashi1, Masatoshi Ishigami2, Yoji Ishizu1, Teiji Kuzuya1, Takashi Honda1, Akihiro Itoh1, Yoshiki Hirooka1, Tetsuya Ishikawa1, Isao Nakano1, Yoshinori Ito3, Hiroshi Kimura4, Yoshiaki Katano5, Hidemi Goto1.   

Abstract

Hepatitis B virus (HBV) has been classified into 10 major genotypes, and HBV genotypes C and B are found in the majority of Japanese patients. However, the prevalence of genotype A has been increasing in patients with chronic or acute hepatitis. Here we report a pediatric case of HBV subgenotype A2. A 2-year-old girl was referred to our hospital for liver damage caused by HBV infection. During the pregnancy, her father had developed acute sporadic hepatitis B. The child was born without any complications. She did not receive HBV vaccination at birth because her mother was negative for HBs antigen at the pre-delivery screening; however, her mother developed acute hepatitis B 2 months after delivery. At that time, HBs antigen was detected in the current patient. Phylogenetic full-length sequence analysis revealed HBV subgenotype A2. HBV sequencing was not performed for her parents; therefore, the intrafamilial transmission routes in these cases are unclear, although the authors speculate that, for the current patient, mother-to-child transmission may have occurred. This report illustrates the pitfalls of the selective vaccination strategy in Japan for preventing HBV infection. Universal vaccination to prevent HBV infection might be useful in Japan.

Entities:  

Keywords:  HBV genotype A; Hepatitis B virus; Universal vaccination

Year:  2013        PMID: 26181835     DOI: 10.1007/s12328-013-0402-1

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  14 in total

Review 1.  Hepatitis B virus infection--natural history and clinical consequences.

Authors:  Don Ganem; Alfred M Prince
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

2.  Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan.

Authors:  E Orito; T Ichida; H Sakugawa; M Sata; N Horiike; K Hino; K Okita; T Okanoue; S Iino; E Tanaka; K Suzuki; H Watanabe; S Hige; M Mizokami
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

3.  Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001.

Authors:  Mariko Kobayashi; Fumitaka Suzuki; Yasuji Arase; Norio Akuta; Yoshiyuki Suzuki; Tetsuya Hosaka; Satoshi Saitoh; Masahiro Kobayashi; Akihito Tsubota; Takashi Someya; Kenji Ikeda; Marie Matsuda; Junko Sato; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2004-09       Impact factor: 7.527

4.  Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan.

Authors:  Kazuhiko Hayashi; Yoshiaki Katano; Yasushi Takeda; Takashi Honda; Masatoshi Ishigami; Akihiro Itoh; Yoshiki Hirooka; Isao Nakano; Motoyoshi Yano; Hidemi Goto; Kentaro Yoshioka; Hidenori Toyoda; Takashi Kumada
Journal:  J Med Virol       Date:  2007-04       Impact factor: 2.327

5.  Does the spread of hepatitis B virus genotype A increase the risk of intrafamilial transmission in Japan?

Authors:  Haruki Komatsu; Hidenori Sugawara; Ayano Inui; Kenjiro Nagamine; Eitaro Hiejima; Tsuyoshi Sogo; Tomoo Fujisawa
Journal:  J Infect Chemother       Date:  2010-08-18       Impact factor: 2.211

Review 6.  Global control of hepatitis B virus infection.

Authors:  Jia-Horng Kao; Ding-Shinn Chen
Journal:  Lancet Infect Dis       Date:  2002-07       Impact factor: 25.071

7.  Causes of vertical transmission of hepatitis B virus under the at-risk prevention strategy in Japan.

Authors:  Yuka Torii; Hiroshi Kimura; Kazuhiko Hayashi; Michio Suzuki; Jun-Ichi Kawada; Seiji Kojima; Yoshiaki Katano; Hidemi Goto; Yoshinori Ito
Journal:  Microbiol Immunol       Date:  2013-02       Impact factor: 1.955

8.  Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980-1994.

Authors:  Hiroshi Noto; Toshihiko Terao; Shigeo Ryou; Yasuyuki Hirose; Takami Yoshida; Hideo Ookubo; Hidetoshi Mito; Hiroshi Yoshizawa
Journal:  J Gastroenterol Hepatol       Date:  2003-08       Impact factor: 4.029

9.  A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J.

Authors:  Kanako Tatematsu; Yasuhito Tanaka; Fuat Kurbanov; Fuminaka Sugauchi; Shuhei Mano; Tatsuji Maeshiro; Tomokuni Nakayoshi; Moriaki Wakuta; Yuzo Miyakawa; Masashi Mizokami
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

Review 10.  The global impact of vaccination against hepatitis B: a historical overview.

Authors:  Alessandro R Zanetti; Pierre Van Damme; Daniel Shouval
Journal:  Vaccine       Date:  2008-10-09       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.